Founder and CEO
Ashley earned her DVM from University of Florida, completed residency training in companion exotics at UC Davis and her PhD from Stanford in Cancer Biology. She has been working at the intersection of human and animal health with a focus on translating findings from veterinary medicine and non-model organisms.
Founder and CSO
Katie earned her PhD in Human Medical Genetics at the University of Colorado, Anschutz Medical Campus. She next trained as a postdoctoral scholar in computational biology in Dr. Carlos Bustamante’s lab as Stanford. Her research has focused on utilizing proteomic, transcriptomic and genomic approaches to identify the molecular components underlying the highly dynamic phenotype of hibernation.
Founder and CtO
Linda earned an MPhil in Computational Biology from the University of Cambridge and her Ph.D. in Genetics and Genomics from Harvard University. She previously held positions at the Broad Institute and Stanford University studying comparative mammalian genomics and human disease genetics.
DR. CARLOS BUSTAMANTE
Chair of the Department of Biomedical Data Science at Stanford University
DR. SANDY MARTIN
Professor of Cell and Developmental Biology at the University of Colorado, Denver
DR. MICHAEL KENT
Director Clinical trials & Oncology at the University of California, Davis
DR. ALLYSON HINDLE
Assistant Professor at Harvard University / Massachusetts General Hospital
DR. MATTHEW ANDREWS
Director of Vertebrate Genome Biology at the Broad Institute of MIT and Harvard
DR. JASON RAVENAL
Director, Portfolio Strategy
DR. THOMAS HUGHES
President and CSO at Navitor Pharmaceuticals
DR. ELINOR KARLSSON